Jasper Therapeutics CFO Herb Cross to resign, interim officers namedSep 28PeopleJasper Therapeutics, Inc.
Jasper Therapeutics receives Nasdaq notice over stockholders' equity shortfallAug 26PartnershipJasper Therapeutics, Inc.
Jasper Therapeutics reports Q2 2026 results after closing Kira Pharmaceuticals mergerAug 14Quarterly updateJasper Therapeutics, Inc.
Jasper Therapeutics discloses $132 million private securities offering in SEC filingAug 4FinancingJasper Therapeutics, Inc.
Jasper Therapeutics completes all-stock merger with Kira Pharmaceuticals, adds $132 million PIPEJul 16M&AbriquilimabJasper Therapeutics, Inc.
Jasper Therapeutics completes all-stock merger with Kira PharmaceuticalsJul 16M&AJasper Therapeutics, Inc.
Sign in